FDA Approval History
This list consists of medications tracked by drugclasses.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Enzeevu (aflibercept-abzv) - August 09, 2024
- neffy (epinephrine) - August 09, 2024
- Yorvipath (palopegteriparatide) - August 09, 2024
- Crexont (carbidopa and levodopa) - August 07, 2024
- Lymphir (denileukin diftitox-cxdl) - August 07, 2024
- Zurnai (nalmefene hydrochloride) - August 07, 2024
- Voranigo (vorasidenib) - August 06, 2024
- Tecelra (afamitresgene autoleucel) - August 01, 2024
- Erzofri (paliperidone palmitate) - July 26, 2024
- Zunveyl (benzgalantamine) - July 26, 2024
- Leqselvi (deuruxolitinib phosphate) - July 25, 2024
- Femlyv (ethinyl estradiol and norethindrone acetate) - July 22, 2024
- Epysqli (eculizumab-aagh) - July 19, 2024
- Kisunla (donanemab-azbt) - July 02, 2024
- Ahzantive (aflibercept-mrbb) - June 28, 2024
- Nypozi (filgrastim-txid) - June 28, 2024
- Pyzchiva (ustekinumab-ttwe) - June 28, 2024
- Ohtuvayre (ensifentrine) - June 26, 2024
- Tepylute (thiotepa) - June 25, 2024
- PiaSky (crovalimab-akkz) - June 20, 2024